Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase III OPTIMUM study of ponesimod in relapsing MS meets primary endpoint

July 26, 2019

First results presented for reparixin in pancreatic islet transplantation in type 1 diabetes

July 26, 2019

Novel pigenin derivative with anti-ischemic and neuroprotective effects following ischemia in rats

July 26, 2019

Activation of neuronal TRPV1 is sufficient to cause the equivalent of psoriasis

July 26, 2019

Impetis Biosciences discovers adenosine A2A and/or A2B receptor antagonists

July 26, 2019

Metallo-beta-lactamase inhibitors synthesized at Merck & Co.

July 26, 2019

Indoleamine 2,3-dioxygenase 1 inhibitors identified at Bristol-Myers Squibb

July 26, 2019

TILRR is a new therapeutic target for treating vaginal HIV-1 infection

July 26, 2019

Sanford Burnham Prebys Medical Discovery Institute patents ACP1 inhibitors

July 26, 2019

Roche describes antibodies targeting vascular endothelial growth factor A

July 26, 2019

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...